Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets

Ovarian cancer is one of the most common gynecological malignancies in women, with a poor prognosis and high mortality. With the expansion of single-cell RNA sequencing technologies, the inner biological mechanism involved in tumor recurrence should be explored at the single-cell level, and novel pr...

Full description

Bibliographic Details
Main Authors: Yongjian Zhang, Wei Huang, Dejia Chen, Yue Zhao, Fusheng Sun, Zhiqiang Wang, Ge Lou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.823082/full
_version_ 1828729337472352256
author Yongjian Zhang
Wei Huang
Dejia Chen
Yue Zhao
Fusheng Sun
Zhiqiang Wang
Ge Lou
author_facet Yongjian Zhang
Wei Huang
Dejia Chen
Yue Zhao
Fusheng Sun
Zhiqiang Wang
Ge Lou
author_sort Yongjian Zhang
collection DOAJ
description Ovarian cancer is one of the most common gynecological malignancies in women, with a poor prognosis and high mortality. With the expansion of single-cell RNA sequencing technologies, the inner biological mechanism involved in tumor recurrence should be explored at the single-cell level, and novel prognostic signatures derived from recurrence events were urgently identified. In this study, we identified recurrence-related genes for ovarian cancer by integrating two Gene Expression Omnibus datasets, including an ovarian cancer single-cell RNA sequencing dataset (GSE146026) and a bulk expression dataset (GSE44104). Based on these recurrence genes, we further utilized the merged expression dataset containing a total of 524 ovarian cancer samples to identify prognostic signatures and constructed a 13-gene risk model, named RMGS (recurrence marker gene signature). Based on the RMGS score, the samples were stratified into high-risk and low-risk groups, and these two groups displayed significant survival difference in two independent validation cohorts including The Cancer Genome Atlas (TCGA). Also, the RMGS score remained significantly independent in multivariate analysis after adjusting for clinical factors, including the tumor grade and stage. Furthermore, there existed close associations between the RMGS score and immune characterizations, including checkpoint inhibition, EMT signature, and T-cell infiltration. Finally, the associations between RMGS scores and molecular subtypes revealed that samples with mesenchymal subtypes displayed higher RMGS scores. In the meanwhile, the genomics characterization from these two risk groups was also identified. In conclusion, the recurrence-related RMGS model we identified could provide a new understanding of ovarian cancer prognosis at the single-cell level and offer a reference for therapy decisions for patient treatment.
first_indexed 2024-04-12T14:30:57Z
format Article
id doaj.art-d04df1bf0f8d4398b248b20afbe05ab2
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-12T14:30:57Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-d04df1bf0f8d4398b248b20afbe05ab22022-12-22T03:29:17ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-06-011310.3389/fgene.2022.823082823082Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression DatasetsYongjian ZhangWei HuangDejia ChenYue ZhaoFusheng SunZhiqiang WangGe LouOvarian cancer is one of the most common gynecological malignancies in women, with a poor prognosis and high mortality. With the expansion of single-cell RNA sequencing technologies, the inner biological mechanism involved in tumor recurrence should be explored at the single-cell level, and novel prognostic signatures derived from recurrence events were urgently identified. In this study, we identified recurrence-related genes for ovarian cancer by integrating two Gene Expression Omnibus datasets, including an ovarian cancer single-cell RNA sequencing dataset (GSE146026) and a bulk expression dataset (GSE44104). Based on these recurrence genes, we further utilized the merged expression dataset containing a total of 524 ovarian cancer samples to identify prognostic signatures and constructed a 13-gene risk model, named RMGS (recurrence marker gene signature). Based on the RMGS score, the samples were stratified into high-risk and low-risk groups, and these two groups displayed significant survival difference in two independent validation cohorts including The Cancer Genome Atlas (TCGA). Also, the RMGS score remained significantly independent in multivariate analysis after adjusting for clinical factors, including the tumor grade and stage. Furthermore, there existed close associations between the RMGS score and immune characterizations, including checkpoint inhibition, EMT signature, and T-cell infiltration. Finally, the associations between RMGS scores and molecular subtypes revealed that samples with mesenchymal subtypes displayed higher RMGS scores. In the meanwhile, the genomics characterization from these two risk groups was also identified. In conclusion, the recurrence-related RMGS model we identified could provide a new understanding of ovarian cancer prognosis at the single-cell level and offer a reference for therapy decisions for patient treatment.https://www.frontiersin.org/articles/10.3389/fgene.2022.823082/fullovarian cancersingle-cell RNA-seqprognostic modelimmune subtypesrecurrence
spellingShingle Yongjian Zhang
Wei Huang
Dejia Chen
Yue Zhao
Fusheng Sun
Zhiqiang Wang
Ge Lou
Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
Frontiers in Genetics
ovarian cancer
single-cell RNA-seq
prognostic model
immune subtypes
recurrence
title Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
title_full Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
title_fullStr Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
title_full_unstemmed Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
title_short Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
title_sort identification of a recurrence gene signature for ovarian cancer prognosis by integrating single cell rna sequencing and bulk expression datasets
topic ovarian cancer
single-cell RNA-seq
prognostic model
immune subtypes
recurrence
url https://www.frontiersin.org/articles/10.3389/fgene.2022.823082/full
work_keys_str_mv AT yongjianzhang identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets
AT weihuang identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets
AT dejiachen identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets
AT yuezhao identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets
AT fushengsun identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets
AT zhiqiangwang identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets
AT gelou identificationofarecurrencegenesignatureforovariancancerprognosisbyintegratingsinglecellrnasequencingandbulkexpressiondatasets